Dexcom traded at $79.64 this Tuesday September 27th, decreasing $0.71 or 0.88 percent since the previous trading session. Looking back, over the last four weeks, Dexcom lost 4.49 percent. Over the last 12 months, its price fell by 40.67 percent. Looking ahead, we forecast Dexcom to be priced at 78.26 by the end of this quarter and at 71.47 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
79.64
Daily Change
-0.88%
Yearly
-40.67%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 244.40 1.91 0.79% -26.22%
Abbott 98.33 -1.51 -1.51% -17.69%
Align Technology 214.22 -5.42 -2.47% -68.37%
AtriCure 38.25 -0.68 -1.75% -45.71%
Avanos Medical Inc 21.56 -0.15 -0.69% -31.77%
Baxter International 54.30 -0.61 -1.11% -32.74%
Becton, Dickinson and Co. 228.34 -3.30 -1.42% -9.31%
Boston Scientific 38.14 -0.22 -0.57% -12.66%
Cooper Companies 263.81 -5.19 -1.93% -37.78%
Cardiovascular Systems 13.30 0.09 0.68% -60.02%
Dexcom 79.64 -0.71 -0.88% -40.67%
Edwards Lifesciences 82.37 -1.22 -1.46% -27.66%
Globus Medical 58.06 -0.29 -0.50% -26.30%
Hologic 63.71 0.05 0.08% -12.57%
Integra LifeSciences 42.28 -0.44 -1.03% -40.05%
Inogen 22.74 -0.10 -0.44% -49.47%
J&J 164.94 -0.76 -0.46% 1.31%
Masimo 140.01 -0.06 -0.04% -48.50%
Medtronic 80.89 -0.44 -0.54% -36.10%
Merit Medical Systems 55.05 0.75 1.38% -23.36%
NuVasive 43.24 -0.06 -0.14% -30.28%
Insulet 230.59 -1.00 -0.43% -16.62%
Roche Holding 312.60 6.70 2.19% -6.01%
Sientra 0.50 -0.02 -4.38% -90.71%
Stryker 202.68 -0.58 -0.29% -24.34%
Teleflex 201.97 -2.37 -1.16% -47.87%
Tandem Diabetes Care 46.53 1.20 2.65% -60.47%
West Pharmaceutical Services 246.39 -6.44 -2.55% -42.36%
Zimmer Biomet Holdings Inc 104.82 -0.33 -0.31% -30.51%

Indexes Price Day Year
USND 10830 26.58 0.25% -25.55%
US2000 1663 6.63 0.40% -25.44%
USNDX 11188 17.64 0.16% -24.17%
US500 3630 -7.75 -0.21% -16.73%

Dexcom
Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.